Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (41-50 of 8,366) with videos related to

Pageof 837
Sort By:
Drugs|June 22, 2016
Sugammadex: A Review of Neuromuscular Blockade ReversalGillian M Keating
Drugs|June 12, 2016
Pain Relief for Acute Urolithiasis: The Case for Non-Steroidal Anti-Inflammatory DrugsPeter L Steinberg, Steven L Chang
Drugs|June 18, 2016
Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and ManagementAnna Chang, Susan H Fox
Drugs|May 28, 2016
Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?Lucia Festino, Gerardo Botti, Paul Lorigan, et al.
Drugs|July 30, 2015
Apremilast: A Review in Psoriasis and Psoriatic ArthritisEmma D Deeks
Drugs|July 30, 2015
Nivolumab: A Review in Advanced MelanomaLesley J Scott
Drugs|July 3, 2013
Mirabegron: a review of its use in patients with overactive bladder syndromeMark Sanford
Drugs|May 25, 2012
Epidemiology and management of Kawasaki diseaseNadia J C Luca, Rae S M Yeung
Drugs|May 25, 2012
The role of capecitabine in locally advanced rectal cancer treatment: an updateCarlos Fernández-Martos, Miquel Nogué, Paloma Cejas, et al.
Drugs|May 25, 2012
Immune globulin subcutaneous (human) 20%: in primary immunodeficiency disordersPaul L McCormack
Pageof 837

Showing results (41-50 of 8,366) with videos related to

Sort By:
Pageof 837
Drugs|June 22, 2016
Sugammadex: A Review of Neuromuscular Blockade ReversalGillian M Keating
Drugs|June 12, 2016
Pain Relief for Acute Urolithiasis: The Case for Non-Steroidal Anti-Inflammatory DrugsPeter L Steinberg, Steven L Chang
Drugs|June 18, 2016
Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and ManagementAnna Chang, Susan H Fox
Drugs|May 28, 2016
Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?Lucia Festino, Gerardo Botti, Paul Lorigan, et al.
Drugs|July 30, 2015
Apremilast: A Review in Psoriasis and Psoriatic ArthritisEmma D Deeks
Drugs|July 30, 2015
Nivolumab: A Review in Advanced MelanomaLesley J Scott
Drugs|July 3, 2013
Mirabegron: a review of its use in patients with overactive bladder syndromeMark Sanford
Drugs|May 25, 2012
Epidemiology and management of Kawasaki diseaseNadia J C Luca, Rae S M Yeung
Drugs|May 25, 2012
The role of capecitabine in locally advanced rectal cancer treatment: an updateCarlos Fernández-Martos, Miquel Nogué, Paloma Cejas, et al.
Drugs|May 25, 2012
Immune globulin subcutaneous (human) 20%: in primary immunodeficiency disordersPaul L McCormack
Pageof 837